SOX9 and non-small cell lung carcinoma: In addition, a recent study has highlighted overexpression of SOX9 expression in NSCLC cells treated with chemotherapeutic cisplatin, while SOX9 knockdown results in augmented cisplatin sensitivity of NSCLC [24].